Cannabinol

Generic Name
Cannabinol
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C21H26O2
CAS Number
521-35-7
Unique Ingredient Identifier
7UYP6MC9GH
Background

Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.

Associated Conditions
-
Associated Therapies
-
championnews.com.ng
·

CBN to launch new website on Monday

CBN's redesigned website, www.cbn.gov.ng, launches on Dec 2, 2024, offering expanded info on its mandate and mobile responsiveness. The redesign was guided by public feedback.
newswire.ca
·

Charlotte's Web Reports 2024 Third Quarter Financial Results

Charlotte's Web reports Q3 2024 financial results, highlighting sequential quarterly growth and new product innovations driving omni-channel expansion. Key initiatives include e-commerce platform upgrades, product launches, and partnerships with retailers like Walmart. The company introduced Soft Gel Capsules and Functional Mushroom Gummies, expanding its product portfolio. Charlotte's Web also expanded its distribution channels and improved operational efficiencies, aiming to enhance consumer engagement and market presence.
arise.tv
·

NEPZA, Free Trade Zone Operators Urge CBN to Fast-Track Offshore Banking Approval

NEPZA and FTZ operators urge CBN to expedite offshore banking approval to ease forex access and business challenges, citing benefits like stable financial environment and asset protection.
theglobeandmail.com
·

Tilray Brands Launches Charlotte's Web™ CBD Gummies in Canada

Tilray Brands launches Charlotte's Web CBD gummies in Canada, offering 25mg gummies in Berry & Fruit and Turmeric & Ginger flavors for daily CBD consumers.
tribuneonlineng.com
·

Deconstructing the SEC's time to market initiative

The SEC has implemented initiatives to reduce time to market, aiming to improve efficiency and attractiveness of the Nigerian capital market, promoting economic growth. These include streamlined registration processes, electronic filing systems, and enhanced regulatory frameworks, which benefit capital market development through increased liquidity, investor confidence, and resource allocation efficiency.
© Copyright 2024. All Rights Reserved by MedPath